These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1347900)

  • 1. p53 codon 249ser mutations in hepatocellular carcinoma patients with low aflatoxin exposure.
    Patel P; Stephenson J; Scheuer PJ; Francis GE
    Lancet; 1992 Apr; 339(8797):881. PubMed ID: 1347900
    [No Abstract]   [Full Text] [Related]  

  • 2. p53 codon 249ser hot-spot mutation in HBV-negative hepatocellular carcinoma.
    Yap EP; Cooper K; Maharaj B; McGee JO
    Lancet; 1993 Jan; 341(8839):251. PubMed ID: 8093542
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure?
    Lasky T; Magder L
    Environ Health Perspect; 1997 Apr; 105(4):392-7. PubMed ID: 9189703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma: from gene to public health.
    Montesano R; Hainaut P; Wild CP
    J Natl Cancer Inst; 1997 Dec; 89(24):1844-51. PubMed ID: 9414172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 mutation in hepatocellular carcinoma after aflatoxin exposure.
    Ozturk M
    Lancet; 1991 Nov; 338(8779):1356-9. PubMed ID: 1682737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point mutations of the P53 gene, human hepatocellular carcinoma and aflatoxins.
    Gerbes AL; Caselmann WH
    J Hepatol; 1993 Sep; 19(2):312-5. PubMed ID: 8301066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53 codon 249 mutation in hepatocellular carcinomas from Nigeria.
    Ndububa DA; Yakicier CM; Ojo OS; Adeodu OO; Rotimi O; Ogunbiyi O; Ozturk M
    Afr J Med Med Sci; 2001; 30(1-2):125-7. PubMed ID: 14510167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutations in nonmalignant human liver: fingerprints of aflatoxins?
    Ozturk M
    Hepatology; 1995 Feb; 21(2):600-1. PubMed ID: 7843737
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
    El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
    J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent aflatoxin exposure and mutation at codon 249 of the human p53 gene: lack of association.
    Hsieh DP; Atkinson DN
    Food Addit Contam; 1995; 12(3):421-4. PubMed ID: 7664937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal.
    Coursaget P; Depril N; Chabaud M; Nandi R; Mayelo V; LeCann P; Yvonnet B
    Br J Cancer; 1993 Jun; 67(6):1395-7. PubMed ID: 8390289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
    J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in Turkey.
    Ozdemir FT; Tiftikci A; Sancak S; Eren F; Tahan V; Akın H; Gündüz F; Kedrah AE; Ustündağ Y; Avşar E; Tözün N; Ozdoğan O
    J Gastrointest Cancer; 2010 Sep; 41(3):185-9. PubMed ID: 20306157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma 249Ser p53 mutation in patients with hepatocellular carcinoma residing in a high risk area.
    Dong-Dong L; Xi-Ran Z
    J Cell Mol Med; 2003; 7(1):89-92. PubMed ID: 12767266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The aflatoxin-induced TP53 mutation at codon 249 (R249S): biomarker of exposure, early detection and target for therapy.
    Gouas D; Shi H; Hainaut P
    Cancer Lett; 2009 Dec; 286(1):29-37. PubMed ID: 19376640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mutation of codon 249 in the p53 gene is not specific in Japanese hepatocellular carcinoma.
    Hayashi H; Sugio K; Matsumata T; Adachi E; Urata K; Tanaka S; Sugimachi K
    Liver; 1993 Oct; 13(5):279-81. PubMed ID: 8259041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 and hepatocellular carcinoma.
    Puisieux A; Ozturk M
    Pathol Biol (Paris); 1997 Dec; 45(10):864-70. PubMed ID: 9769950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.
    Soini Y; Chia SC; Bennett WP; Groopman JD; Wang JS; DeBenedetti VM; Cawley H; Welsh JA; Hansen C; Bergasa NV; Jones EA; DiBisceglie AM; Trivers GE; Sandoval CA; Calderon IE; Munoz Espinosa LE; Harris CC
    Carcinogenesis; 1996 May; 17(5):1007-12. PubMed ID: 8640905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aflatoxin and liver cancer.
    Jackson PE; Groopman JD
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Dec; 13(4):545-55. PubMed ID: 10654919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.